<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01320514</url>
  </required_header>
  <id_info>
    <org_study_id>Endoscopic Browlift</org_study_id>
    <nct_id>NCT01320514</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Fibrin Sealant (FS) VH S/D-APR for Hemostasis and Wound Healing in Endoscopic Browlift</brief_title>
  <official_title>A Randomized, Controlled Study to Evaluate Safety and Efficacy of Fibrin Sealant VH S/D 4 S-APR (Artiss) for Tissue Adherence and Hemostasis and To Improve Wound Healing in Subjects Undergoing Endoscopic Browlift</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nguyen, Davis B., M.D.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter BioScience</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Nguyen, Davis B., M.D.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to evaluate the safety and efficacy of Artiss (Fibrin Sealant) in
      reducing the incidence of early postoperative bruising and swelling.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <completion_date type="Anticipated">May 2011</completion_date>
  <primary_completion_date type="Anticipated">May 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of ecchymosis and edema</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resolution of ecchymosis and edema, incidence of hematoma/seroma</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Compare Ecchymosis and Edema for Fibrin Sealant and no Fibrin Sealant</condition>
  <arm_group>
    <arm_group_label>Fibrin Sealant (Artiss)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fibrin Sealant (Artiss)</intervention_name>
    <arm_group_label>Fibrin Sealant (Artiss)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects planned for endoscopic browlift; healthy female or male; age 18-75
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects planned for endoscopic browlift, subjects who read, understand and sign the
             written informed consent, healthy female or male subjects, 18-75 years old, and
             subjects who are able and willing to comply with the protocal requirements

        Exclusion Criteria:

          -  Subjects who had previous browlift, subjects indicated for concurrent facial
             surgeries, subjects considered to be active smokers, subjects with ecchymosis/edema on
             day 0, significant laboratory abnormalities, subjects with known bleeding or
             coagulation disorders, subjects treated with anti-coagulants.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Davis B Nguyen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Davis B Nguyen, M.D.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Davis B Nguyen, MD</last_name>
    <phone>310 550 0288</phone>
    <email>nguyendavisb@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Davis B Nguyen, M.D.</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davis B Nguyen, M.D.</last_name>
      <phone>310-550-0288</phone>
      <email>nguyendavisb@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2010</study_first_submitted>
  <study_first_submitted_qc>March 19, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2011</study_first_posted>
  <last_update_submitted>March 19, 2011</last_update_submitted>
  <last_update_submitted_qc>March 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2011</last_update_posted>
  <responsible_party>
    <name_title>Davis B Nguyen, M.D.</name_title>
    <organization>Davis B Nguyen, M.D.</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ecchymosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
    <mesh_term>Fibrin Tissue Adhesive</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

